Astex Pharmaceuticals (ASTX) Q2 2012 Earnings Call July 30, 2012 4:30 pm ET Executives Timothy L. Enns - Senior Vice President of Investor Relations, Business Development & Corporate Communications James S. J. Manuso - Chairman and Chief Executive Officer Michael Molkentin - Chief Financial Officer, Principal Accounting Officer and Corporate Secretary Mohammad Azab - Chief Medical Officer Analysts Boris Peaker - Oppenheimer & Co. Inc., Research Division Robin Davison - Edison Investment Research Limited George B. Zavoico - McNicoll, Lewis & Vlak LLC, Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Astex Pharmaceuticals Quarter 2 2012 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to your host for today, Mr. Timothy Enns, Senior Vice President, Corporate Communications and Marketing. Sir, you may begin. Timothy L. Enns Thank you, operator. Good day, and thank you for joining us for Astex Pharmaceuticals 2012 Second Quarter Financial Results Conference Call. With me today are Dr. James Manuso, Chairman and Chief Executive Officer; Dr. Harren Jhoti, President and member of the Board of Directors; Dr. Mohammad Azab, Chief Medical Officer; Dr. Martin Buckland, Chief Business Officer; and Michael Molkentin, Chief Financial Officer. In a few moments, Jim Manuso and Michael Molkentin will deliver remarks on the 2012 second quarter financial results and our business outlook for the year. After prepared comments, we will open the line for questions. Earlier today, we issued a press release with our financial results. A copy of the press release is available in the Investor Relations section of our website at www.astx.com.